Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Medication for Graves’ Disease in Children
source: NYU Langone Hospitals
year: N/A
summary/abstract:Doctors at Hassenfeld Children’s Hospital at NYU Langone prescribe medications to treat children with Graves’ disease, an autoimmune disorder. That means the immune system attacks the thyroid and makes it produce too much thyroid hormone. Our doctors often recommend medication to decrease the production of these hormones and to diminish their effects on the body.
Doctors may prescribe an antithyroid medication called methimazole to slow the production of thyroid hormones. Methimazole is often effective in children who have mild symptoms of Graves’ disease. Your child takes this medication daily, by mouth.
Your child may begin to notice improvements in symptoms, such as reduced eye irritation, weight gain, and less sensitivity to temperature, after taking antithyroid medication for several weeks. Antithyroid therapy may be continued for several months, until the immune system reaction that triggered the condition subsides.
read moreRelated Content
-
A Prospective Study of the Effects of Radioiodine Therapy for Hyperthyroidism in Patients With Minimally Active Grav...Context: Radioiodine is an effective an...
-
Drug Versus Radioactive Treatment of Graves’ Disease – Metabolic OutcomesBackground: Weight gain is a common com...
-
FDA Drug Safety Communication: New Boxed Warning on Severe Liver Injury With PropylthiouracilThe United States Food and Drug Administ...
-
Comparison of Efficacy and Adverse Effects Between Methimazole 15 Mg+Inorganic Iodine 38 Mg/Day and Methimazole 30 M...Background: Methimazole (MMI) is usuall...
-
Risk Factors of Hepatic Dysfunction in Patients With Graves’ Hyperthyroidism and the Efficacy of 131iodine Tre...Hepatic dysfunction is often observed in...
-
Impaired Immune Regulation After Radioiodine Therapy for Graves’ Disease and the Protective Effect of Methimaz...Both therapies for Graves' disease (GD),...
-
Predicting Risk of Recurrent Thyrotoxicosis Following Thionamide Withdrawal in Graves’ DiseaseBackground/Aim: Thionamides are a safe ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.